Cordlife rolls out non-invasive metabolic screening services for newborn, adults
Dec 04 2013
Cordlife will be offering MetaScreen through their strategic collaboration with Navigene Genetic Science, a genetic diagnostic and research company, Meghnath Roy Chowdhury, MD, CordLife Sciences India, said. MetaScreen, Roy Chowdhury said, is a comprehensive set of metabolic screening test specially designed for both newborn babies and adults. The service can detect as many as 110 inborn errors of metabolism from urine samples. Metabolic disorders are usually not apparent at the time of birth. If left undiagnosed and untreated, the baby can develop irreversible damages. Hence, early detection is critical in preventing adverse effects and providing essential care. Most countries in the European Union and some parts of Asia and the US have already made newborn screening compulsory, he said.
MetaScreen is a natural extension of Indian parents’ desire for better healthcare options for their children. Providing parents with early critical information on the health status of the child will help ensure the future welfare of the child.
“Understanding your health is necessary for optimal living. As with most disease states, preventive care and the ability to predict what we are at risk for at the earliest stages is ideal. With the ability to test biochemical markers for individual risk factor assessment and implement interventions to improve or prevent disease state, the path to optimal health becomes clearer. This advanced technology, which is widely accepted over 52 countries over the world, is now being made available in India. This will take forward our vision to provide superior mother and child care services for the community in large,” said Roy Chowdhury.